NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.20+0.23 (+2.89%)
Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%
NeuroPace operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NeuroPace's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.24M. For fiscal 2025 it was -$11.01M. The highest annual figure on record is -$11.01M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.01M | – |
| FY2024 | Dec 31, 2024 | -$17.95M | – |
| FY2023 | Dec 31, 2023 | -$19.70M | – |
| FY2022 | Dec 31, 2022 | -$36.87M | – |
| FY2021 | Dec 31, 2021 | -$24.58M | – |
| FY2020 | Dec 31, 2020 | -$21.61M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.90M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.90M | – |
| Q4 FY2025 | Dec 31, 2025 | $506.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.94M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.48M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.80M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.72M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.90M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.53M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.34M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.30M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.36M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.70M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.84M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.98M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.66M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.39M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.42M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.01M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.94M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.42M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.43M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.21M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.55M | – |
See a number that looks wrong?